ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q907. A total of 4 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $1,296,000 | – | 16,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 25,300 | $3,690,000 | 0.21% |
| GROUP ONE TRADING, L.P. | 89,600 | $13,068,000 | 0.02% |
| JANE STREET GROUP, LLC | 213,200 | $31,095,000 | 0.01% |
| SIMPLEX TRADING, LLC | 20,100 | $2,931,000 | 0.00% |
| JPMORGAN CHASE & CO | 84,100 | $12,266,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |